NCT07417787

Point of Care Tests in the Management of Very Early Medical Abortion

Point of Care Testing for Human Chorionic Gonadotropin (HCG) to Improve Access to Very Early Medical Abortion and Simplify the Follow up Process

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 130 (estimated)
• Sponsor: University of Edinburgh · Academic / Other
• Sex: Female
• Age: 16 Years – 55 Years
• Healthy volunteers: Not accepted

Summary

This study will investigate the use of a point of care test in patients who are having an abortion at a gestation of \<6 weeks (known as a very early medical abortion). These patients have pregnancy hormone level checked at Day 0 and Day 7 to see if treatment has worked. The investigators plan to use a point of care test machine to see if it is possible to check pregnancy hormone level earlier than Day 7.

Conditions

• Abortion Early

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	Blood test	Patients will undergo one additional blood test than is usual with standard care, to measure Human Chorionic Gonadotropin (HCG) level which will be analysed on a point of care test machine and in the lab
OTHER	Participant Questionnaire	The investigators will administer participant questionnaires to both staff and patients to understand opinions on the point of care test machine

Timeline

• Start date: 2026-04-23
• Primary completion: 2027-02-01
• Completion: 2028-02-01
• First posted: 2026-02-18
• Last updated: 2026-04-07

Locations

3 sites across 2 countries: Sweden, United Kingdom